# Exostar Life Sciences

> Exostar Life Sciences is the life sciences business of Exostar, LLC. Its cloud-based Secure Access Manager connects sponsors, clinical sites, CROs and application providers through reusable identities, single sign-on, delegated administration and access reporting.

- **Founded:** 2000
- **Headquarters:** Herndon, United States
- **Founders:** BAE Systems (Founding organization of parent company Exostar in 2000), The Boeing Company (Founding organization of parent company Exostar in 2000), Lockheed Martin (Founding organization of parent company Exostar in 2000), Raytheon (Founding organization of parent company Exostar in 2000), Rolls-Royce (Founding organization of parent company Exostar in 2000)
- **Products:** Secure Access Manager (SAM), Life Sciences Identity Hub, Application integration and professional services
- **Notable:** Merck EngageZone, using Exostar IAM, won the 2013 ISE North America Health Care Project of the Year award., Veeva Vault joined the identity hub in 2015., SAM connects 122+ applications according to Exostar marketing.

## Products & services

- **Secure Access Manager (SAM)** — Cloud identity and access service for clinical research, combining registration, authentication, single sign-on, delegated administration and access reporting; documented in production by 2013.
- **Life Sciences Identity Hub** — Connect-once identity federation community linking life sciences organizations, users and applications; SAM controls authenticated access.
- **Application integration and professional services** — Standards-based application connections and implementation support for clinical technology environments.

## Achievements

- Merck EngageZone, using Exostar IAM, won the 2013 ISE North America Health Care Project of the Year award.
- Veeva Vault joined the identity hub in 2015.
- SAM connects 122+ applications according to Exostar marketing.
- An Exostar Q2 2025 anonymous pharmaceutical case study reports 25% faster user onboarding, 86% fewer passwords managed and 50% faster responses to access-audit queries; vendor-reported, not independently audited.

## Latest updates

- **2026-07** — Exostar published a life sciences access-management explainer describing more than 920,000 users across 36,000 organizations.
- **2026-06** — The MyExostar SAM overview was updated June 1 and linked SAM 6.7 release notes.
- **2025-12** — Exostar published guidance on verified clinical onboarding, federated access and permissions that expire.
- **2025-06** — A Q2 2025 case study described SAM adoption by an unnamed global top-ten pharmaceutical company; June is the quarter-end indexing month, not a confirmed publication day.

## Links

- Website: https://www.exostar.com/industries/life-sciences/
- LinkedIn: https://www.linkedin.com/company/exostar-life-sciences
- Twitter/X: https://twitter.com/exostar
- YouTube: https://www.youtube.com/@Exostarllc
- Facebook: https://www.facebook.com/pages/Exostar/467240016721876

---

Profile page: https://yespress.io/exostar-life-sciences
Published by YesPress — https://yespress.io
Last updated: 2026-10-23